EMAIL THIS PAGE TO A FRIEND

Biomaterials

Sequential release of nanoparticle payloads from ultrasonically burstable capsules.


PMID 26496382

Abstract

In many biomedical contexts ranging from chemotherapy to tissue engineering, it is beneficial to sequentially present bioactive payloads. Explicit control over the timing and dose of these presentations is highly desirable. Here, we present a capsule-based delivery system capable of rapidly releasing multiple payloads in response to ultrasonic signals. In vitro, these alginate capsules exhibited excellent payload retention for up to 1 week when unstimulated and delivered their entire payloads when ultrasonically stimulated for 10-100 s. Shorter exposures (10 s) were required to trigger delivery from capsules embedded in hydrogels placed in a tissue model and did not result in tissue heating or death of encapsulated cells. Different types of capsules were tuned to rupture in response to different ultrasonic stimuli, thus permitting the sequential, on-demand delivery of nanoparticle payloads. As a proof of concept, gold nanoparticles were decorated with bone morphogenetic protein-2 to demonstrate the potential bioactivity of nanoparticle payloads. These nanoparticles were not cytotoxic and induced an osteogenic response in mouse mesenchymal stem cells. This system may enable researchers and physicians to remotely regulate the timing, dose, and sequence of drug delivery on-demand, with a wide range of clinical applications ranging from tissue engineering to cancer treatment.

Related Materials

Product #

Image

Description

Molecular Formula

Add to Cart

M8168
4-Methylumbelliferyl phosphate disodium salt, phosphatase substrate
C10H7Na2O6P
449644
Barium chloride, anhydrous, beads, −10 mesh, 99.999% trace metals basis
BaCl2
449652
Barium chloride, anhydrous, beads, −10 mesh, 99.95% trace metals basis
BaCl2
202738
Barium chloride, 99.999% trace metals basis
BaCl2
342920
Barium chloride, 99.9% trace metals basis
BaCl2
SRP3326
BMP-2 human, Animal-component free, recombinant, expressed in E. coli, ≥98% (SDS-PAGE), ≥98% (HPLC)
SRP6155
BMP-2 human, recombinant, expressed in HEK 293 cells, ≥95% (SDS-PAGE)
B3555
Bone Morphogenetic Protein 2 human, ≥98% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
H4791
Bone Morphogenetic Protein 2 human, BMP-2, recombinant, expressed in HEK 293 cells, HumanKine®, suitable for cell culture
B1814
Bone Morphogenetic Protein 2 human, Carrier Free, ≥98% (SDS-PAGE), recombinant, expressed in E. coli, lyophilized powder, cell culture tested
C5670
Calcium chloride, anhydrous, BioReagent, suitable for insect cell culture, suitable for plant cell culture, ≥96.0%
CaCl2
429759
Calcium chloride, anhydrous, beads, −10 mesh, ≥99.99% trace metals basis
CaCl2
499609
Calcium chloride, anhydrous, powder, 99.99% trace metals basis
CaCl2
C8106
Calcium chloride, meets USP testing specifications
CaCl2 · 2H2O
449709
Calcium chloride, anhydrous, beads, −10 mesh, ≥99.9% trace metals basis
CaCl2
21115
Calcium chloride solution, BioUltra, for molecular biology, ~1 M in H2O
CaCl2
S5770
Citrate Concentrated Solution, BioReagent, suitable for coagulation assays, 4 % (w/v)
C6H5Na3O7
83273
Citrate Concentrated Solution, BioUltra, for molecular biology, 1 M in H2O
C6H5Na3O7
A5960
L-Ascorbic acid, BioXtra, ≥99.0%, crystalline
C6H8O6
A7506
L-Ascorbic acid, reagent grade, crystalline
C6H8O6
A0278
L-Ascorbic acid, reagent grade
C6H8O6
A4403
L-Ascorbic acid, powder, cell culture tested, γ-irradiated
C6H8O6
A4544
L-Ascorbic acid, suitable for cell culture, suitable for plant cell culture, ≥98%
C6H8O6
A2218
L-Ascorbic acid, meets USP testing specifications
C6H8O6
A2174
L-Ascorbic acid, plant cell culture tested
C6H8O6
A2343
L-Ascorbic acid, meets USP testing specifications
C6H8O6
95209
L-Ascorbic acid, BioUltra, ≥99.5% (RT)
C6H8O6
33034
L-Ascorbic acid, puriss. p.a., ACS reagent, reag. ISO, reag. Ph. Eur., 99.7-100.5% (oxidimetric)
C6H8O6
95210
L-Ascorbic acid, puriss. p.a., ≥99.0% (RT)
C6H8O6
47863
L-Ascorbic acid, analytical standard
C6H8O6